Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Daunorubicin citrate |
Is a |
False |
Daunorubicin (substance) |
Inferred relationship |
Some |
|
Daunorubicin hydrochloride |
Is a |
False |
Daunorubicin (substance) |
Inferred relationship |
Some |
|
Poisoning by daunorubicin |
Causative agent (attribute) |
True |
Daunorubicin (substance) |
Inferred relationship |
Some |
1 |
Accidental daunorubicin poisoning |
Causative agent (attribute) |
False |
Daunorubicin (substance) |
Inferred relationship |
Some |
|
Intentional daunorubicin poisoning |
Causative agent (attribute) |
False |
Daunorubicin (substance) |
Inferred relationship |
Some |
|
intoxication par la daunorubicine d'intention indéterminée |
Causative agent (attribute) |
False |
Daunorubicin (substance) |
Inferred relationship |
Some |
1 |
Liposomal daunorubicin 2mg/mL injection emulsion 25mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Daunorubicin (substance) |
Inferred relationship |
Some |
|
Product containing precisely daunorubicin (as daunorubicin hydrochloride) 20 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Daunorubicin (substance) |
Inferred relationship |
Some |
|
Product containing daunorubicin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Daunorubicin (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely daunorubicin (as daunorubicin hydrochloride) 5 milligram/1 milliliter conventional release solution for injection (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Daunorubicin (substance) |
Inferred relationship |
Some |
|
Daunorubicin liposome (substance) |
Is a |
False |
Daunorubicin (substance) |
Inferred relationship |
Some |
|
Accidental daunorubicin poisoning |
Causative agent (attribute) |
True |
Daunorubicin (substance) |
Inferred relationship |
Some |
1 |
Intentional daunorubicin poisoning |
Causative agent (attribute) |
True |
Daunorubicin (substance) |
Inferred relationship |
Some |
1 |
Daunorubicin-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Daunorubicin (substance) |
Inferred relationship |
Some |
1 |
Daunorubicin hydrochloride |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Daunorubicin (substance) |
Inferred relationship |
Some |
|
Daunorubicin liposome (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Daunorubicin (substance) |
Inferred relationship |
Some |
|
Daunorubicin citrate |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Daunorubicin (substance) |
Inferred relationship |
Some |
|
Product containing precisely daunorubicin (as daunorubicin hydrochloride) 20 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Daunorubicin (substance) |
Inferred relationship |
Some |
1 |
Product containing only daunorubicin in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Daunorubicin (substance) |
Inferred relationship |
Some |
1 |
Product containing only daunorubicin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Daunorubicin (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely daunorubicin (as daunorubicin hydrochloride) 5 milligram/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Daunorubicin (substance) |
Inferred relationship |
Some |
1 |
Product containing only cytarabine and daunorubicin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Daunorubicin (substance) |
Inferred relationship |
Some |
1 |
Product containing cytarabine and daunorubicin in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Daunorubicin (substance) |
Inferred relationship |
Some |
1 |
Product containing cytarabine and daunorubicin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Daunorubicin (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely cytarabine 100 milligram and daunorubicin 44 milligram/1 vial powder for conventional release solution for infusion (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Daunorubicin (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely cytarabine 100 milligram and daunorubicin 44 milligram/1 vial powder for conventional release solution for infusion (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Daunorubicin (substance) |
Inferred relationship |
Some |
1 |
Product containing only cytarabine and daunorubicin in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Daunorubicin (substance) |
Inferred relationship |
Some |
1 |